Galecto, Inc. (DMRA) vs Taysha Gene Therapies, Inc. (TSHA)
- Galecto, Inc. DMRA 23.67 +8.28%
- Taysha Gene Therapies, Inc. TSHA 4.35 +6.36%
Galecto, Inc. and Taysha Gene Therapies, Inc. are both Biotechnology companies. Galecto, Inc. and Taysha Gene Therapies, Inc. are of similar size ($1.4B and $1.3B). Taysha Gene Therapies, Inc. has negative trailing earnings, so its P/E is not meaningful; Galecto, Inc. trades at 24.7×. Across the 10 metrics below, Galecto, Inc. leads on 7 and Taysha Gene Therapies, Inc. on 3.
Valuation
Profitability
| Metric | DMRA | TSHA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (39.51%) | (47.05%) | (51.96%) |
| Return on assets | (27.08%) | (37.23%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack